City
McKinney Fire Department
Drugs and doses39
A–C Acetaminophen, Adenosine, Albuterol, Amiodarone, Aspirin, Atropine, Calcium Chloride, Calcium Gluconate, Cefepime9
Acetaminophen
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1000 mg | IV/IO | not captured | standing | pages 64, 79, 86, 126, 134 |
| Other | peds | 15 mg/kg (max 1000 mg) | PO | not captured | standing | page 132 |
| Other | peds | 15 mg/kg (max 1000 mg) | IV/IO | not captured | standing | pages 64, 79, 86, 126, 134 |
| Other | peds | 15 mg/kg (max 1000 mg) | PO/PR | not captured | standing | page 132 |
Adenosine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Narrow-complex tachycardia | adult | 12 mg | IV/IO | not captured | standing | pages 93, 96, 139, 141, 142 |
| Narrow-complex tachycardia | peds | 0.1 mg/kg (max 12 mg) | IV/IO | not captured | standing | pages 93, 96, 139, 141, 142 |
Albuterol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hyperkalemia | adult | 2.5–7.5 mg | NEB | not captured | standing | pages 60, 153 |
| Other | adult | 2.5–7.5 mg | NEB | not captured | standing | pages 36, 37, 82, 83, 101, 102, 129, 130 |
| Other | adult | 2.5–7.5 mg | NEB | not captured | standing | page 36 |
| Other | peds | 2.5–7.5 mg | NEB | not captured | standing | page 101 |
Amiodarone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 150 mg | IV/IO | not captured | standing | page 47 |
| Other | adult | 300 mg | IV/IO | not captured | standing | pages 46, 47, 109, 139, 141 |
| Other | peds | 5 mg/kg | IV/IO | not captured | standing | pages 46, 47, 109, 139, 141 |
Aspirin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 325 mg | PO | not captured | standing | pages 50, 53 |
Atropine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Bradycardia | adult | 1 mg | IV/IO | not captured | standing | pages 41, 106 |
| Bradycardia | peds | 0.02 mg/kg | IV/IO | not captured | standing | pages 41, 106 |
| Organophosphate poisoning | adult | 3 mg | IV/IO | not captured | standing | pages 76, 124 |
| Organophosphate poisoning | peds | 0.02 mg/kg | IV/IO | not captured | standing | pages 76, 124 |
Calcium Chloride
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiac arrest | adult | 1 g | IV/IO | not captured | standing | pages 45, 60, 108 |
| Cardiac arrest | peds | 20 mg/kg | IV/IO | not captured | standing | pages 45, 60, 108 |
Calcium Gluconate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiac arrest | adult | 3 g | IV/IO | not captured | standing | pages 45, 60, 108 |
| Cardiac arrest | peds | 60 mg/kg | IV/IO | not captured | standing | pages 45, 60, 108 |
| Hyperkalemia | adult | 1 g | IV/IO | not captured | standing | page 60 |
| Other | adult | 1 g | IV/IO | not captured | standing | page 68 |
| Other | adult | 1 g | IV/IO | not captured | standing | page 160 |
| Other | peds | 60 mg/kg (max 1 g) | IV/IO | not captured | standing | page 160 |
| Trauma / hemorrhage | adult | 1 g | IV/IO | not captured | standing | pages 88, 135, 160 |
| Trauma / hemorrhage | peds | 60 mg/kg | IV/IO | not captured | standing | pages 88, 135, 160 |
Cefepime
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Sepsis | adult | 2 g | IV/IO | not captured | standing | page 87 |
| Sepsis | adult | 2 g | IM | not captured | standing | page 87 |
| Sepsis | adult | 2 g | IV/IO | not captured | standing | pages 87, 121 |
| Sepsis | peds | 50 mg/kg | IV/IO | not captured | standing | pages 87, 121 |
| Trauma / hemorrhage | adult | 2 g | IV/IO | not captured | standing | pages 87, 121 |
| Trauma / hemorrhage | adult | 2 g | IM | not captured | standing | pages 87, 121 |
| Trauma / hemorrhage | peds | 50 mg/kg | IV/IO | not captured | standing | pages 87, 121 |
| Trauma / hemorrhage | peds | 50 mg/kg | IM | not captured | standing | pages 87, 121 |
D–F Dexamethasone, Dextrose, Diltiazem, Diphenhydramine, Droperidol, Epinephrine, Etomidate, Fentanyl8
Dexamethasone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Adrenal crisis | adult | 10 mg | IV/IO/IM | not captured | standing | pages 33, 100 |
| Adrenal crisis | peds | 0.6 mg/kg | IV/IO/IM | not captured | standing | pages 33, 100 |
| Croup | peds | 0.6 mg/kg | IV/IO/IM/PO | not captured | standing | pages 129, 130 |
| Other | adult | 10 mg | IV/IO/IM | not captured | standing | pages 36, 101 |
| Other | adult | 10 mg | IV/IO/IM | not captured | standing | pages 37, 102 |
| Other | peds | 0.6 mg/kg | IV/IO/IM | not captured | standing | pages 36, 101 |
| Other | peds | 0.6 mg/kg | IV/IO/IM | not captured | standing | pages 37, 102 |
| Other | peds | 0.6 mg/kg | IV/IO/IM/PO | not captured | standing | pages 129, 130 |
Dextrose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 100 mL | IV/IO | not captured | standing | pages 55, 116 |
| Hypoglycemia | peds | 5 mL/kg | IV/IO | not captured | standing | pages 55, 116 |
Diltiazem
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Atrial fibrillation with RVR | adult | 5–10 mg | IV/IO | not captured | standing | page 96 |
| Other | adult | 10–20 mg | IV/IO | not captured | standing | page 96 |
| Other | adult | 5 mg | IV | not captured | standing | page 96 |
| Narrow-complex tachycardia | adult | 5–10 mg | IV/IO | not captured | standing | page 96 |
Diphenhydramine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 25–50 mg | IV/IO/IM/PO | not captured | standing | pages 36, 101 |
| Allergic reaction | adult | 50 mg | IV/IO/IM/PO | not captured | standing | pages 36, 101 |
| Allergic reaction | peds | 1 mg/kg | IV/IO/IM/PO | not captured | standing | pages 36, 101 |
| Allergic reaction | peds | 1 mg/kg | IV/IO/IM/PO | not captured | standing | pages 36, 101 |
| Anaphylaxis | adult | 50 mg | IV/IO/IM | not captured | standing | pages 37, 102 |
| Anaphylaxis | peds | 1 mg/kg | IV/IO/IM | not captured | standing | pages 37, 102 |
| Dystonic reaction | adult | 25–50 mg | IV/IO/IM | not captured | standing | pages 64, 65, 76, 79, 81, 123 |
| Dystonic reaction | peds | 1 mg/kg | IV/IO/IM | not captured | standing | pages 64, 65, 76, 79, 81, 123 |
| Other | adult | 25–50 mg | IV/IO/IM | not captured | standing | page 76 |
| Other | peds | 1 mg/kg | IV/IO/IM/PO | not captured | standing | page 101 |
| Other | peds | 1 mg/kg | IV/IO/IM/PO | not captured | standing | page 101 |
| Other | peds | 1 mg/kg | IV/IO/IM | not captured | standing | page 102 |
Droperidol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 10 mg | IV/IO/IM | not captured | standing | page 81 |
| Nausea / vomiting | adult | 1.25–2.5 mg | IV/IO/IM | not captured | standing | page 65 |
| Other | adult | 1.25–2.5 mg | IV/IO/IM | not captured | standing | page 64 |
| Other | adult | 5 mg | IV/IO/IM | not captured | standing | page 81 |
| Mild to moderate pain | adult | 1.25–2.5 mg | IV/IO/IM | not captured | standing | page 79 |
Epinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 0.5 mg | IM | not captured | standing | pages 37, 102 |
| Anaphylaxis | peds | 0.01 mg/kg | IM | not captured | standing | pages 37, 102 |
| Other | adult | 1–2 mL | IV/IO | not captured | standing | pages 34, 100 |
| Other | adult | 1–2 mL | IV/IO | not captured | standing | pages 37, 103 |
| Other | adult | 1–2 mL | IV/IO | not captured | standing | page 41 |
| Other | peds | 0.01 mg/kg | IM | not captured | standing | page 130 |
| Other | peds | 0.01 mg/kg | IV/IO | not captured | standing | pages 46, 109, 110 |
| Other | peds | 1 mL | IV/IO | not captured | standing | pages 34, 100 |
| Other | peds | 1 mL | IV/IO | not captured | standing | pages 37, 103 |
Etomidate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.1 mg/kg | IV/IO | not captured | standing | pages 93, 139, 164 |
| Other | adult | 0.3 mg/kg | IV/IO | not captured | standing | page 191 |
| Other | peds | 0.1 mg/kg | IV/IO | not captured | standing | pages 93, 139, 164 |
| Other | peds | 0.3 mg/kg | IV/IO | not captured | standing | page 191 |
| Procedural sedation | adult | 0.1 mg/kg | IV/IO | not captured | standing | page 164 |
| Procedural sedation | peds | 0.1 mg/kg | IV/IO | not captured | standing | page 164 |
| RSI induction | adult | 0.3 mg/kg | IV/IO | not captured | standing | page 191 |
| RSI induction | peds | 0.3 mg/kg | IV/IO | not captured | standing | page 191 |
| Narrow-complex tachycardia | adult | 0.1 mg/kg | IV/IO | not captured | standing | pages 93, 139 |
| Narrow-complex tachycardia | peds | 0.1 mg/kg | IV/IO | not captured | standing | pages 93, 139 |
Fentanyl
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1–2 mcg/kg (max 200 mcg) | IV/IO | not captured | standing | page 193 |
| Other | adult | 2 mcg/kg (max 200 mcg) | IN | not captured | standing | page 78 |
| Other | peds | 1–2 mcg/kg (max 100 mcg) | IV/IO | not captured | standing | page 193 |
| Other | peds | 2 mcg/kg (max 100 mcg) | IN | not captured | standing | page 125 |
| Mild to moderate pain | adult | 1 mcg/kg | IV/IO | not captured | standing | pages 51, 78, 125 |
| Mild to moderate pain | adult | 1 mcg/kg | IM | not captured | standing | pages 78, 125 |
| Mild to moderate pain | peds | 1 mcg/kg | IV/IO | not captured | standing | pages 51, 78, 125 |
| Mild to moderate pain | peds | 1 mcg/kg | IM | not captured | standing | pages 78, 125 |
| Mild to moderate pain | peds | 2 mcg/kg | IN | not captured | standing | pages 78, 125 |
| Post-intubation sedation | adult | 1–2 mcg/kg | IV/IO | not captured | standing | page 193 |
| Post-intubation sedation | peds | 1–2 mcg/kg | IV/IO | not captured | standing | page 193 |
G–L Hydrocortisone, Hydroxocobalamin, Ipratropium, Ketamine, Labetalol, Lidocaine6
Hydrocortisone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Adrenal crisis | adult | 100 mg | IM | not captured | standing | pages 33, 100 |
| Adrenal crisis | peds | 1–2 mg/kg | IM | not captured | standing | pages 33, 100 |
Hydroxocobalamin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cyanide poisoning | adult | 5 g | IV | not captured | standing | pages 42, 112 |
| Cyanide poisoning | peds | 70 mg/kg | IV | not captured | standing | pages 42, 112 |
Ipratropium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 500–1500 mcg | NEB | not captured | standing | pages 36, 101 |
| Anaphylaxis | adult | 500–1500 mcg | NEB | not captured | standing | pages 37, 102 |
| Other | adult | 500–1500 mcg | NEB | not captured | standing | pages 82, 129 |
| Other | adult | 500–1500 mcg | NEB | not captured | standing | pages 83, 130 |
| Other | adult | 500–1500 mcg | NEB | not captured | standing | page 36 |
| Other | peds | 500–1500 mcg | NEB | not captured | standing | page 101 |
Ketamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 1 mg/kg | IV/IO/IN | not captured | standing | pages 81, 128 |
| Agitation | adult | 2–4 mg/kg | IM | not captured | standing | pages 81, 128 |
| Other | adult | 1 mg/kg | IV/IO | not captured | standing | pages 45, 108 |
| Other | adult | 1 mg/kg | IV/IO/IM | not captured | standing | pages 84, 132 |
| Other | adult | 1 mg/kg (max 100 mg) | IV/IO | not captured | standing | page 193 |
| Other | adult | 1 mg/kg | IV/IO | not captured | standing | page 193 |
| Other | adult | 1.5 mg/kg | IV/IO | not captured | standing | page 192 |
| Other | adult | 1.5 mg/kg | IV/IO | not captured | standing | page 191 |
| Other | adult | 1.5 mg/kg (max 150 mg) | IV/IO | not captured | standing | page 190 |
| Other | peds | 1 mg/kg | IV/IO/IM | not captured | standing | pages 84, 132 |
| Other | peds | 1 mg/kg (max 50 mg) | IV/IO/IM | not captured | standing | page 132 |
| Other | peds | 1 mg/kg (max 50 mg) | IV/IO | not captured | standing | page 193 |
| Other | peds | 1 mg/kg | IV/IO | not captured | standing | page 193 |
| Other | peds | 1.5 mg/kg | IV/IO | not captured | standing | page 192 |
| Other | peds | 1.5 mg/kg | IV/IO | not captured | standing | page 191 |
| Other | peds | 1.5 mg/kg (max 75 mg) | IV/IO | not captured | standing | page 190 |
| Other | peds | 2–4 mg/kg (max 200 mg) | IM | not captured | standing | page 128 |
| Mild to moderate pain | adult | 0.3 mg/kg | IV/IO/IN | not captured | standing | pages 78, 125 |
| Mild to moderate pain | adult | 0.3 mg/kg | IM | not captured | standing | pages 78, 125 |
| Mild to moderate pain | peds | 0.3 mg/kg | IV/IO/IN | not captured | standing | pages 78, 125 |
| Mild to moderate pain | peds | 0.3 mg/kg | IM | not captured | standing | pages 78, 125 |
| Post-intubation sedation | adult | 1 mg/kg | IV/IO | not captured | standing | page 193 |
| Post-intubation sedation | peds | 1 mg/kg | IV/IO | not captured | standing | page 193 |
| RSI induction | adult | 1.5 mg/kg | IV/IO | not captured | standing | page 191 |
| RSI induction | peds | 1.5 mg/kg | IV/IO | not captured | standing | page 191 |
Labetalol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Eclampsia / pre-eclampsia | adult | 20 mg | IV/IO | not captured | standing | pages 67, 68 |
| Other | adult | 10–20 mg | IV/IO | not captured | standing | page 61 |
| Stroke | adult | 10–20 mg | IV/IO | not captured | standing | page 90 |
Lidocaine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 2 mL | IO | not captured | standing | page 176 |
| Other | peds | 0.5 mg/kg (max 40 mg) | IO | not captured | standing | page 176 |
M–O Magnesium Sulfate, Methylprednisolone, Midazolam, Morphine, Naloxone, Nitroglycerin, Ondansetron, Oxymetazoline8
Magnesium Sulfate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 2 g | IV/IO | not captured | standing | pages 83, 130 |
| Asthma / bronchospasm | peds | 50 mg/kg | IV/IO | not captured | standing | pages 83, 130 |
| Eclampsia / pre-eclampsia | adult | 4 g | IV/IO | not captured | standing | pages 67, 68 |
| Eclampsia / pre-eclampsia | adult | 5 g | IM | not captured | standing | pages 67, 68 |
| Other | adult | 2 g | IV/IO | not captured | standing | pages 46, 109 |
| Other | peds | 50 mg/kg (max 2 g) | IV/IO | not captured | standing | pages 46, 109 |
Methylprednisolone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Adrenal crisis | adult | 125 mg | IV/IO/IM | not captured | standing | pages 33, 100 |
| Adrenal crisis | peds | 2 mg/kg (max 100 mg) | IV/IO/IM | not captured | standing | pages 33, 100 |
| Allergic reaction | adult | 125 mg | IV/IO/IM | not captured | standing | pages 36, 37, 101, 102 |
| Allergic reaction | peds | 2 mg/kg (max 100 mg) | IV/IO/IM | not captured | standing | pages 36, 37, 101, 102 |
| Other | adult | 125 mg | IV/IO/IM | not captured | standing | pages 82, 83, 129, 130 |
| Other | peds | 2 mg/kg (max 100 mg) | IV/IO/IM | not captured | standing | pages 82, 83, 129, 130 |
Midazolam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | peds | 0.05 mg/kg (max 2.5 mg) | IV/IO/IN | not captured | standing | pages 40, 105 |
| Agitation | peds | 0.05 mg/kg (max 2.5 mg) | IM | not captured | standing | pages 40, 105 |
| Eclampsia / pre-eclampsia | adult | 10 mg | IM | not captured | standing | page 68 |
| Eclampsia / pre-eclampsia | adult | 5 mg | IV/IO/IN | not captured | standing | page 68 |
| Other | adult | 0.1 mg/kg (max 10 mg) | IV/IO | not captured | standing | page 193 |
| Other | adult | 1–2.5 mg | IV/IO/IN | not captured | standing | page 51 |
| Other | adult | 1–2.5 mg | IM | not captured | standing | page 51 |
| Other | adult | 2.5–5 mg | IV/IO/IN | not captured | standing | pages 81, 128 |
| Other | adult | 2.5–5 mg | IM | not captured | standing | pages 81, 128 |
| Other | peds | 0.1 mg/kg (max 5 mg) | IV/IO/IN | not captured | standing | pages 81, 128 |
| Other | peds | 0.1 mg/kg (max 5 mg) | IM | not captured | standing | pages 81, 128 |
| Other | peds | 0.1 mg/kg (max 5 mg) | IV/IO | not captured | standing | page 193 |
| Post-intubation sedation | adult | 5–10 mg | IV/IO | not captured | standing | page 193 |
| Post-intubation sedation | peds | 0.1 mg/kg (max 5 mg) | IV/IO | not captured | standing | page 193 |
| Seizure | adult | 10 mg | IM | not captured | standing | pages 84, 132 |
| Seizure | adult | 5 mg | IV/IO/IN | not captured | standing | pages 84, 132 |
| Seizure | peds | 0.2 mg/kg (max 10 mg) | IM | not captured | standing | pages 84, 132 |
| Seizure | peds | 0.2 mg/kg (max 5 mg) | IV/IO/IN | not captured | standing | pages 84, 132 |
Morphine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 2–4 mg | IV/IO | not captured | standing | page 51 |
| Mild to moderate pain | adult | 2–8 mg | IV/IO | not captured | standing | pages 51, 78, 125 |
| Mild to moderate pain | adult | 2–8 mg | IM | not captured | standing | pages 78, 125 |
| Mild to moderate pain | peds | 0.1 mg/kg (max 4 mg) | IV/IO | not captured | standing | pages 51, 78, 125 |
| Mild to moderate pain | peds | 0.1 mg/kg (max 4 mg) | IM | not captured | standing | pages 78, 125 |
Naloxone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Opioid overdose | adult | 0.4–2 mg | IV/IO/IM/IN/NEB | not captured | standing | pages 39, 76, 104, 123 |
| Opioid overdose | peds | 0.1 mg/kg | IV/IO/IM/IN/NEB | not captured | standing | pages 39, 76, 104, 123 |
| Other | adult | 0.4–2 mg | IV/IO/IM/IN/NEB | not captured | standing | page 39 |
| Other | peds | 0.1 mg/kg | IV/IO/IM/IN/NEB | not captured | standing | page 104 |
Nitroglycerin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 0.4 mg | SL | not captured | standing | pages 50, 216 |
| CHF / pulmonary edema | adult | 0.8 mg | SL | not captured | standing | page 53 |
Ondansetron
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 4 mg | IV/IO/IM/IN/PO | not captured | standing | pages 64, 65, 120, 217 |
| Nausea / vomiting | peds | 0.1 mg/kg | IV/IO/IM/IN/PO | not captured | standing | pages 64, 65, 120, 217 |
| Nausea / vomiting | peds | 0.1 mg/kg | IV/IO/IM/IN/PO | not captured | standing | page 120 |
Oxymetazoline
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1 mL | NEB | not captured | standing | pages 57, 117, 218 |
| Other | adult | 1 mL | IN | not captured | standing | pages 57, 117 |
| Other | peds | 1 mL | IN | not captured | standing | pages 57, 117 |
P–R Plasma, Proparacaine, Rocuronium3
Plasma
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1 unit | IV/IO | not captured | standing | page 160 |
| Other | peds | 1 unit/kg | IV/IO | not captured | standing | page 160 |
| Trauma / hemorrhage | adult | 1 unit | IV/IO | not captured | standing | page 160 |
| Trauma / hemorrhage | peds | 10 mL/kg | IV/IO | not captured | standing | page 160 |
Proparacaine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1–2 drop | OPH | not captured | standing | pages 75, 122 |
| Other | adult | 1–2 drop | OPH | not captured | standing | pages 75, 122 |
| Other | peds | 1–2 drop | OPH | not captured | standing | pages 75, 122 |
| Other | peds | 1–2 drop | OPH | not captured | standing | pages 75, 122 |
Rocuronium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1.5 mg/kg | IV/IO | not captured | standing | pages 45, 108 |
| Other | adult | 1.5 mg/kg | IV/IO | not captured | standing | page 191 |
| Other | peds | 1.5 mg/kg | IV/IO | not captured | standing | page 191 |
| Post-intubation sedation | adult | 1.5 mg/kg | IV/IO | not captured | standing | page 193 |
| Post-intubation sedation | peds | 1.5 mg/kg | IV/IO | not captured | standing | page 193 |
| RSI induction | adult | 1.5 mg/kg | IV/IO | not captured | standing | pages 191, 192 |
| RSI induction | peds | 1.5 mg/kg | IV/IO | not captured | standing | pages 191, 192 |
S–Z Sodium Bicarbonate, Succinylcholine, Terbutaline, Tranexamic Acid, Whole Blood5
Sodium Bicarbonate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hyperkalemia | adult | 1 mEq/kg | IV/IO | not captured | standing | pages 45, 60, 108 |
| Other | adult | 1 mEq/kg | IV/IO | not captured | standing | page 153 |
| Tricyclic overdose | adult | 1 mEq/kg | IV/IO | not captured | standing | pages 45, 76, 108, 124 |
| Tricyclic overdose | peds | 1 mEq/kg | IV/IO | not captured | standing | pages 45, 76, 108, 124 |
Succinylcholine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1.5 mg/kg | IV/IO | not captured | standing | pages 45, 108 |
| Other | adult | 1.5 mg/kg | IV/IO | not captured | standing | page 191 |
| Other | peds | 1.5 mg/kg | IV/IO | not captured | standing | page 191 |
| RSI induction | adult | 1.5 mg/kg | IV/IO | not captured | standing | page 191 |
| RSI induction | peds | 1.5 mg/kg | IV/IO | not captured | standing | page 191 |
Terbutaline
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 0.25 mg | SQ | not captured | standing | pages 83, 130 |
| Asthma / bronchospasm | peds | 0.01 mg/kg | SQ | not captured | standing | pages 83, 130 |
Tranexamic Acid
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1 g | IV/IO | not captured | standing | page 38 |
| Other | adult | 2 g | IV/IO | not captured | standing | page 160 |
| Other | adult | 500 mg | IN | not captured | standing | pages 57, 117 |
| Other | adult | 500 mg | NEB | not captured | standing | pages 57, 117 |
| Other | adult | 500 mg | IN | not captured | standing | pages 57, 117 |
| Other | adult | 500 mg | NEB | not captured | standing | pages 57, 117 |
| Other | peds | 15 mg/kg (max 2 g) | IV/IO | not captured | standing | page 160 |
| Other | peds | 250 mg | IN | not captured | standing | pages 57, 117 |
| Other | peds | 250 mg | NEB | not captured | standing | pages 57, 117 |
| Other | peds | 500 mg | IN | not captured | standing | pages 57, 117 |
| Other | peds | 500 mg | NEB | not captured | standing | pages 57, 117 |
| Trauma / hemorrhage | adult | 2 g | IV/IO | not captured | standing | page 160 |
| Trauma / hemorrhage | peds | 15 mg/kg | IV/IO | not captured | standing | page 160 |
Whole Blood
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1 unit | IV/IO | not captured | standing | page 160 |
| Other | peds | 1 unit/kg | IV/IO | not captured | standing | page 160 |
| Trauma / hemorrhage | adult | 1 unit | IV/IO | not captured | standing | page 160 |
| Trauma / hemorrhage | peds | 10 mL/kg | IV/IO | not captured | standing | page 160 |
Cite this
McKinney Fire Department, United States EMS Protocol Census. 227 dose entries, effective 2026-09-01.
https://protoquiz.com/census/agencies/mckinney-fire-department/
The census is free and not for sale. Only public agencies are named.